CC
MDT icon

Centiva Capital’s Medtronic MDT Stock Holding History

Centiva Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,020
Closed -$629K – 1408
2021
Q3 		$629K Buy
+5,020
New +$650K 0.04% 541

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Centiva Capital's MDT Position: Q1 2026 in Review

Centiva Capital opened a new position in Medtronic (MDT) in Q1 2026: 22,333 shares worth $1.94M. The stake represents 0.01% of the portfolio and ranks #439 among its holdings. This is a return to the name: Centiva Capital previously reported a position in MDT as recently as Q1 2025.

Centiva Capital first reported a position in MDT in Q4 2019 and has held it in 18 quarters since. The position peaked at $6.94M in Q3 2024. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Centiva Capital held 22,333 shares of Medtronic worth $1.94M as of Q1 2026.
  • Medtronic was a new Centiva Capital position in Q1 2026.
  • Medtronic made up 0.01% of Centiva Capital's portfolio in Q1 2026, its #439 holding.
  • Centiva Capital first reported a position in Medtronic in Q4 2019 and has held it in 18 quarters since.
  • Centiva Capital's Medtronic position peaked at $6.94M in Q3 2024.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.